|
Kurt Krummel, Ph.D. joined Celula in 2006 and is currently the Manager of Biological Applications. Prior to joining Celula, he was a post-doctoral researcher at The Salk Institute (La Jolla, CA). He led a technical team on an NIH funded scientific study of the tumor suppressor gene, p53. This work in mouse models served as a paradigm for understanding transcription factor signaling networks in cancer and resulted in several high profile publications in prestigious peer-reviewed journals. He also routinely reviewed and edited manuscripts for peer-reviewed journal and collaborated with Dr. Geoffrey Wahl in grant writing for postdoctoral and R01 funds. Dr. Krummel received his Bachelor's degree in Biology from The University of Wisconsin (Whitewater, WI), and in 2001, he received his Ph.D. in Molecular Biology from The Mayo Clinic (Rochester, MN). While at Mayo, he characterized and compared novel homologous regions of the human and mouse genomes that are prone to breakage and rearrangement in a variety of cancer types to understand the molecular basis for the instability implicated in tumorigenesis. | 